Fairooz Kabbinavar
Technik-/Wissenschafts-/F&E-Leiter bei CARDIFF ONCOLOGY, INC.
Vermögen: - $ am 31.05.2024
Aktive Positionen von Fairooz Kabbinavar
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CARDIFF ONCOLOGY, INC. | Technik-/Wissenschafts-/F&E-Leiter | 31.01.2023 | - |
Karriereverlauf von Fairooz Kabbinavar
Ehemalige bekannte Positionen von Fairooz Kabbinavar
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
HUYA Bioscience International LLC
HUYA Bioscience International LLC Pharmaceuticals: MajorHealth Technology HUYA Bioscience International LLC develops biopharmaceutical products. It sources pharmaceutical innovation originating in China for global development in international markets. It's lead immune-oncology lead product, HBI-8000, already approved in China, is now in registration trials in Japan and Korea for lymphoma and in clinical trials in the U.S. for various solid tumor indications in combination with the checkpoint inhibitor nivolumab. The company was founded by Mireille Gillings in 2004 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01.01.2021 | 01.02.2023 |
University of California, Los Angeles | Corporate Officer/Principal | 01.07.1991 | 01.10.2016 |
FORTE BIOSCIENCES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 15.04.2019 | - |
Ausbildung von Fairooz Kabbinavar
Nagpur University | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Indien | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 2 |
Corporate Officer/Principal | 2 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
CARDIFF ONCOLOGY, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Tocagen, Inc.
Tocagen, Inc. BiotechnologyHealth Technology Tocagen, Inc. is a clinical-stage, cancer-selective gene therapy company, which engages in the development of product candidates designed to activate a patient's immune system against their own cancer. It is in the business of discovery, development, and commercialization of products for the treatment of cancer. The company was founded by Thomas E. Darcy, Harry E. Gruber, Douglas J. Jolly, and Dennis N. Berman in August 2007 and is headquartered San Diego, CA. | Health Technology |
HUYA Bioscience International LLC
HUYA Bioscience International LLC Pharmaceuticals: MajorHealth Technology HUYA Bioscience International LLC develops biopharmaceutical products. It sources pharmaceutical innovation originating in China for global development in international markets. It's lead immune-oncology lead product, HBI-8000, already approved in China, is now in registration trials in Japan and Korea for lymphoma and in clinical trials in the U.S. for various solid tumor indications in combination with the checkpoint inhibitor nivolumab. The company was founded by Mireille Gillings in 2004 and is headquartered in San Diego, CA. | Health Technology |
- Börse
- Insiders
- Fairooz Kabbinavar
- Erfahrung